Best 3 Blue Chip Stocks to Buy After the Market's Pullback

American Express reported Q4 revenue of $17.18B (+10% YoY) and net income of $2.46B (+13% YoY); management says Millennials and Gen Z comprised 65% of new accounts in 2025 (≈75% of new U.S. consumer Gold/Platinum acquisitions) and the stock yields 1.3%. UnitedHealth posted FY2025 revenue of $447.6B (+12% YoY) but earnings of $19B (‑41% YoY); the stock is down ~46% over the past 12 months and management guides to >$17.75 EPS in 2026 (vs $16.35 in 2025); dividend yield ~3.2%. Enterprise Products Partners had Q4 revenue $13.79B (slightly down YoY), net income $1.64B (up vs $1.62B) and EPS $0.75 (+$0.01), with a 5.8% dividend yield; the piece recommends these dividend-focused blue chips as defensive exposure amid a ~5% pullback in the S&P 500 from highs and heightened Iran-related energy risks.

Analysis

American Express’s win with younger, affluent cohorts is less a one-off marketing victory and more a stretched-duration asset: earlier acquisition compresses payback today but extends lifetime wallet share and cross-sell runway for 5–10 years. That dynamic magnifies sensitivity to credit-cycle inflections — rising rates help NII on revolvers, but an employment shock would hit vintage cohorts hardest in year 2–4 when unsecured balances ramp. The levered way to play this is to treat AXP as a growth-yield hybrid where timing of credit normalization (6–18 months) matters more than headline premium pricing.

UnitedHealth’s current malaise is an execution-and-pricing reset rather than a demand collapse; the key near-term catalysts are Medicare Advantage bid revisions and CMS risk-adjustment cadence over the next 6–12 months. However, the company is exposed to secular medical-cost inflation and regulatory noise (audits, plan enrollment shifts) that can reaccelerate reserve builds and compress forward EPS estimates. Treat any mechanical bounce as a catalyst-driven trade, not a durable re-rate until multiple quarters of margin stabilization are visible.

Enterprise Products Partners offers asymmetric return characteristics: low commodity price beta but high optionality to regional takeaway tightness and logistics dislocation from geopolitical events (weeks–quarters). Midstream economics amplify margin per-barrel when flows are rerouted; conversely, demand shocks cut EBITDA slower but more persistently. Structuring exposure as income-first with defined downside protection captures the long-term structural moat while limiting short-term volatility.

Contrarian view: the market currently underprices timing risk across these names — investors are rewarding yield and customer-growth headlines without paying for 6–18 month operational and credit tail risks. Prefer option-structured entries that monetize current carry while capping drawdowns and leave room for multi-quarter resolution of the cited execution issues.

Key Decisions for Investors

• AXP — 6–12 month buy-write: Buy AXP equity (3–5% portfolio) and sell 6–9 month covered calls ~10–12% OTM to harvest yield; hedge with 6–9 month 6% OTM puts sized to limit drawdown to ~6% of portfolio. Rationale: monetize current carry while protecting against a 6–12 month credit shock.
• UNH — tactical 3–6 month call spread: Buy 3–6 month at-the-money calls and sell 20–30% OTM calls (50–100%/max loss of premium); size as 1–2% of portfolio. Risk/reward: asymmetric if management execution surprises; downside limited to premium paid, upside captured if MA bid repricing materializes.
• EPD — income + tail hedge: Accumulate EPD for yield (4–6% portfolio weight) and sell 4–6 month calls ~8–10% OTM to enhance carry; buy 12–18 month puts 10–15% OTM (small size) as protection against systemic demand collapse or pipeline disruptions. Rationale: capture steady cashflow and optionality to regional takeaway tightness.
• Pair idea — UNH/HUM or UNH/CI (6–12 months): Long UNH vs short a lower-execution peer to isolate successful bid/cost execution; keep gross exposure modest (1–2% net equity) and mark-to-market weekly. Reward is idiosyncratic execution re-rating; risk is sector-wide cost acceleration that hurts both legs.